ACE inhibitors in heart failure. The renin-angiotensin-aldosterone system plays a vital role in developing congestive heart failure (CHF).

The renin-angiotensin-aldosterone system (RAAS) ... Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients.

Cardioprotective effects of ACE inhibition. As the renin–angiotensin system plays such a large role in the development of hypertension and, subsequently, atherosclerosis, studies have examined ...

The enormous success of ACE inhibitors in hypertension and heart failure spurred hope that adding a second drug to block the renin-angiotensin system would yield improved outcomes. Although ...

The three classes of RAS-blocking drugs (ACE inhibitors, ARBs, and direct renin inhibitors) are used to treat hypertension and congestive heart failure. The EMA said ...

These considerations have led to speculation that ACE inhibitors and ARBs might be harmful in patients with Covid-19. 4,5 Although this is only a hypothesis, the argument has aroused potential ...

Plasma renin activity (PRA), the concentration of angiotensinogen (AGT) and angiotensin-converting enzyme (ACE) were measured, and path analysis was applied, after transformation toward normality.

fter reviewing the three drug classes that act on the renin-angiotensin system (ARBs, ACE inhibitors, and direct renin inhibitors), the European Medicines Agency says no two should be combined.

Renin acts at the top of the RAS cascade: It is the enzyme that cleaves angiotensinogen into angiotensin I, which in turn is acted upon by angiotensin-converting enzyme (ACE) to form the ...

New kidney research is raising concerns that long-term use of ACE inhibitors and other drugs commonly prescribed to treat high-blood pressure and heart failure could be contributing to kidney damage.

These patients are often prescribed renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). This ...

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19. 2020-06-18. DOI: 10.1056/NEJMdo005778 ... ARBs and ACE inhibitors increase the expression of ACE2; ...